ESSENTIAL HYPERTENSION
Condition Identity
Essential Hypertension
Chronic cardiovascular disorder
Essential (primary) vs Secondary hypertension
Essential hypertension accounts for 90-95% of all cases; no single identifiable cause
Epidemiology
Risk Factors
- Age >55 years (male), >65 years (female)
- Family history of hypertension or premature cardiovascular disease
- Obesity (BMI >30 kg/mยฒ) and central adiposity
- Sedentary lifestyle
- High dietary sodium intake (>5 g/day)
- Low dietary potassium intake
- Excessive alcohol consumption
- Smoking
- Chronic psychological stress
- Sleep apnoea
- Chronic kidney disease
- Diabetes mellitus
- Dyslipidaemia
- Ethnicity (Black/African heritage: higher risk and severity)
- Socioeconomic deprivation
Signs & Symptoms
- Elevated blood pressure on two or more readings at separate visits
- Fundoscopic changes (AV nicking, flame haemorrhages, papilloedema in hypertensive retinopathy)
- Left ventricular heave or fourth heart sound (S4)
- Renal artery bruit (suggests secondary hypertension)
- Radio-femoral delay (coarctation of aorta)
- Cushingoid features (secondary cause)
- Peripheral oedema (if heart failure)
- Signs of target organ damage: carotid bruits, retinal changes, displaced apex beat
- Usually asymptomatic (hence called the 'silent killer')
- Headache (occipital, early morning) โ mainly in severe hypertension
- Dizziness and lightheadedness
- Tinnitus
- Visual disturbances (blurring, scotomata)
- Epistaxis (nosebleed)
- Palpitations
- Dyspnoea on exertion (if hypertensive heart disease present)
- Chest pain (if ischaemia or aortic dissection)
Complications
DOWNSTREAM CLINICAL COMPLICATIONS & SEQUELAE
- Ischaemic heart disease and myocardial infarction
- Heart failure (hypertensive heart disease)
- Ischaemic and haemorrhagic stroke
- Hypertensive nephropathy and CKD
- Peripheral arterial disease
- Aortic aneurysm and dissection
- Hypertensive retinopathy and visual loss
- Vascular dementia
- Hypertensive emergency / urgency
- Atrial fibrillation
Diagnostic Criteria
DIAGNOSTIC RED FLAGS & EMERGENCY RULE-OUTS
- Hypertensive emergency: SBP >180 with acute end-organ damage (encephalopathy, papilloedema, AKI, acute MI, aortic dissection)
- Accelerated hypertension: rapidly rising BP with grade 3/4 retinopathy
- Suspected aortic dissection (tearing chest/back pain)
- Eclampsia or pre-eclampsia
- Suspected phaeochromocytoma (paroxysmal hypertension, headache, sweating, palpitations)
- Systolic BP โฅ140 mmHg and/or diastolic BP โฅ90 mmHg on โฅ2 separate occasions (ESC/ESH 2018)
- Stage 1: Systolic 130โ139 or diastolic 80โ89 mmHg (ACC/AHA)
- Stage 2: Systolic โฅ140 or diastolic โฅ90 mmHg (ACC/AHA)
- Hypertensive crisis: SBP >180 and/or DBP >120 mmHg
| Condition | Distinguishing Features | Recommended Workup |
|---|---|---|
| White coat hypertension | โ | โ |
| Masked hypertension | โ | โ |
| Secondary hypertension: Renal artery stenosis, primary hyperaldosteronism, phaeochromocytoma, Cushing syndrome, coarctation of aorta, sleep apnoea | โ | โ |
| Drug-induced hypertension (NSAIDs, COCPs, decongestants, stimulants) | โ | โ |
Investigations
Bedside Tests
- Blood pressure measurement: bilateral arm, two readings, 2 separate visits
- 24-hour ambulatory blood pressure monitoring (ABPM) โ gold standard
- Home blood pressure monitoring (HBPM)
- Fundoscopy
- Urine dipstick (protein, blood)
First-Line Diagnostic Tests
- ECG (left ventricular hypertrophy, ischaemia)
- Urine albumin:creatinine ratio
- Serum creatinine and eGFR
- Electrolytes (sodium, potassium)
- Fasting glucose and HbA1c
- Fasting lipid profile
- Full blood count
- Thyroid function (if clinically indicated)
Confirmatory & Specialized Tests
- Echocardiography (left ventricular hypertrophy assessment)
- Renal ultrasound (structural kidney disease)
- Plasma renin:aldosterone ratio (primary hyperaldosteronism)
- 24-hour urinary catecholamines or plasma metanephrines (phaeochromocytoma)
- CT angiography (renal artery stenosis, aortic coarctation)
- Overnight dexamethasone suppression test (Cushing syndrome)
Continuous & Serial Monitoring
- Blood pressure at every clinical encounter
- Annual urine ACR and eGFR
- Annual ECG if baseline LVH
- Annual fasting glucose and lipid profile
Nonpharmacological Management
- DASH diet (Dietary Approaches to Stop Hypertension): low sodium, high potassium, fruit, vegetables, low-fat dairy
- Sodium restriction (<5 g/day or <2 g sodium; reduces SBP by 2โ8 mmHg)
- Regular aerobic exercise: 150 min/week moderate intensity (reduces SBP by 4โ9 mmHg)
- Weight loss: 1 mmHg SBP reduction per 1 kg weight lost
- Alcohol reduction to <14 units/week (male) and <7 units/week (female)
- Smoking cessation
- Stress reduction techniques (mindfulness, relaxation therapy)
- Limit caffeine intake
- Adequate sleep (7โ8 hours/night)
Monitoring
- Target BP <130/80 mmHg (ACC/AHA); <140/90 mmHg (ESC/ESH) for most patients
- <130/80 in diabetes and CKD
- <150/90 in adults >80 years (ESC)
- Absence of symptomatic hypotension
- Renal function and electrolytes 1โ4 weeks after starting ACEi/ARB or diuretic
- Annual eGFR and urine ACR
- Annual fasting glucose and lipid profile
- Review blood pressure 2โ4 weeks after initiating or changing treatment
- Once stable: 3โ6 monthly review
- Annual comprehensive cardiovascular risk review
- BP uncontrolled on 3 agents (including a diuretic): consider specialist referral for resistant HTN
- Suspected secondary hypertension
- Hypertensive emergency
- Significant target organ damage
- BP typically responds within 2โ4 weeks of treatment initiation
- Lifestyle changes take 4โ12 weeks for maximal effect
Prevention
- Population-level sodium reduction strategies
- Cardiovascular risk scoring for targeted prevention
- Maintain healthy body weight
- DASH diet
- Reduce dietary sodium
- Regular physical activity
- Limit alcohol
- Smoking cessation
- Adherence to medication
- Home blood pressure monitoring technique
- Signs of hypertensive emergency
- When to seek urgent care
- Lifestyle modification importance
EMERGENCY RETURN PRECAUTIONS
- Severe headache with confusion or visual changes
- BP >180/120 mmHg
- Chest pain, dyspnoea, or palpitations
- Sudden neurological symptoms (weakness, speech difficulty)
- Haematuria or oliguria
Prognosis
Hypertension is a major and modifiable cardiovascular risk factor. With optimal treatment, the risk of stroke is reduced by 35โ40%, myocardial infarction by 20โ25%, and heart failure by 50%. Life expectancy is reduced by approximately 5 years with uncontrolled hypertension. Adherence to antihypertensive therapy is a significant challenge, with 50% of patients discontinuing within 1 year.
Referral Criteria
ICU & EMERGENCY RESUSCITATION INDICATIONS
- Hypertensive emergency with haemodynamic instability
- Aortic dissection
- Eclampsia with seizures or HELLP syndrome
HOSPITAL ADMISSION INDICATIONS
- Hypertensive emergency (SBP >180 with acute end-organ damage)
- Pre-eclampsia or eclampsia
- Hypertensive encephalopathy
- Acute aortic dissection
- Hypertensive acute heart failure
- Nephrology: suspected renal cause, CKD stage โฅ3, resistant hypertension
- Endocrinology: suspected primary hyperaldosteronism, phaeochromocytoma, Cushing syndrome
- Cardiology: established cardiovascular disease, heart failure, arrhythmia
- Ophthalmology: hypertensive retinopathy
All content in Medobo is for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional and local institutional protocols before administering medication or initiating treatment.